Dual targeting of<scp>l</scp>-carnitine-conjugated nanoparticles to OCTN2 and ATB<sup>0,+</sup>to deliver chemotherapeutic agents for colon cancer therapy
Longfa Kou(Wenzhou Medical University), Vadivel Ganapathy(Texas Tech University), Yinghua Sun(Weifang Medical University), Jin Sun(Shenyang Pharmaceutical University), Sathish Sivaprakasam(Texas Tech University), Qiuhua Luo(Shenyang Pharmaceutical University), Qiang Fu(Peking University), Zhonggui He(Shenyang Pharmaceutical University), Qing Yao(Shenyang Pharmaceutical University)
Cited by 86
Related Papers
GPR109A Is a G-protein–Coupled Receptor for the Bacterial Fermentation Product Butyrate and Functions as a Tumor Suppressor in Colon
|Cancer Research|2009|765
Transporter-Guided Delivery of Nanoparticles to Improve Drug Permeation across Cellular Barriers and Drug Exposure to Selective Cell Types
|Frontiers in Pharmacology|2018|295
Disulfide Bond Bridge Insertion Turns Hydrophobic Anticancer Prodrugs into Self-Assembled Nanomedicines
|Nano Letters|2014|250
Self-facilitated ROS-responsive nanoassembly of heterotypic dimer for synergistic chemo-photodynamic therapy
|Journal of Controlled Release|2019|162
Solid self-emulsifying nitrendipine pellets: Preparation and in vitro/in vivo evaluation
|International Journal of Pharmaceutics|2009|138